Adverse Reactions (3% and Greater than Placebo) in WEGOVY-Treated Pediatric Patients Aged 12 Years and Older with Obesity Acute Pancreatitis In WEGOVY clinical trials in adults, acute pancreatitis was confirmed by adjudication in 4 WEGOVY-treated patients (0.2 cases per 100 patient years) versus 1 in placebo-treated patients (less than 0.1 cases per 100 patient years)
Using the correct volume for 10mg tirzepatide or 30mg tirzepatide ensures accurate dosing
Though rare, side effects can happen
The agency highlighted small sample sizes, inconsistent baseline characteristics, varying regimens, inadequate controls and uncertain clinical relevance
Therefore, various APAP doses were tested to assess susceptibility to APAP-induced toxicity, aiming to investigate potential differences in tolerance between wild-type and hepsin / mice
These studies will let us know more about how safe it is and how well it works when we compare it to other drugs